Macadildig, Vicente S.

HRN: 12-59-45  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/29/2022
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
08/29/2022
09/05/2022
IV
4.5gms
Q6
Empirical Escalation
Waiting Final Action 

Indication:  Empirical Escalation    Type of Infection:  Bloodstream    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: